-transparent.png){kind=logo}
Cutaneous hyperpigmentation resembling acanthosis nigricans developed in two patients with malignant brain tumors following chemotherapy with triazinate (Baker's Antifol), a folic acid antagonist. In both cases, the eruption resolved after the cessation of drug administration and reappeared after the reinstitution of triazinate therapy. A skin biopsy specimen from one patient showed microscopic changes consistent with those found in acanthosis nigricans. The other patient had a decreased serum folate level that returned to normal as the hyperpigmentation resolved. Folate may have a role in triazinate-induced acanthosislike hyperpigmentation.
Related Publications
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
January 1984,
Indian journal of dermatology,
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
December 2014,
Human & experimental toxicology,
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
August 1971,
Die Medizinische Welt,
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
February 1975,
Dermatologische Monatschrift,
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
July 1951,
The Journal of investigative dermatology,
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
January 1997,
Lupus,
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
January 1955,
Archiv fur klinische und experimentelle Dermatologie,
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
February 1964,
Archives of dermatology,
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
July 1955,
A.M.A. archives of dermatology,
A H Greenspan, and
J L Shupack, and
S H Foo, and
A C Wise
January 1975,
Dermatologische Monatschrift,
